Dr. Bijoy Pankaj Telivala, MD

  • Jacksonville, FL
  • Hematologist and oncologist
NPI1790935153PAC ID1658563598
Medicare services, 2024
67,690
Medicare patients, 2024
644
Part D claims, 2024
879
Publications
4
Clinical trials
1
Practice address
7015 A C Skinner Pkwy, Jacksonville, FL 32256
Practice phone
Call (904) 363-2113
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Cancer Specialists of North Florida

Jacksonville, Florida

See all 6 affiliations

Find Dr. Telivala's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Bijoy Pankaj Telivala is a hematologist and oncologist in Jacksonville, Florida

Dr. Telivala practices at Cancer Specialists of North Florida in Jacksonville, Florida.

Dr. Telivala's NPI, 1790935153, was assigned on September 23, 2008. Dr. Telivala graduated from Lokmanya Tilak Municipal Medical College in 2002. Dr. Telivala holds Florida license ME 106137.

NPI and contact details
Medicare PAC ID
1658563598
NPI enumeration date
September 23, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(904) 363-2113
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
50
Medical school graduation
2002

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Bijoy Pankaj Telivala practices at Cancer Specialists of North Florida in Jacksonville, Florida

Dr. Telivala's primary practice is Cancer Specialists of North Florida, at 7015 A C Skinner Pkwy, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 363-2113.

  • Cancer Specialists of North Florida
    7015 A C Skinner Pkwy, Jacksonville, FL 32256 · Duval CountyPhone(904) 363-2113

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Bijoy Pankaj Telivala is affiliated with 5 sites of care and 1 medical group

Dr. Telivala's primary practice is Cancer Specialists of North Florida in Jacksonville, Florida. Dr. Telivala is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Cancer Specialists of North Florida. Dmand AI also links Dr. Telivala to 2 more hospitals and 1 group practice or clinic, each named with a free account.

See all 6 affiliations for Dr. Telivala

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Bijoy Pankaj Telivala's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Telivala practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Cancer Specialists of North FloridaAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Telivala practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Bijoy Pankaj Telivala is one of 693 hematologists and oncologists in Florida

Hematology and oncology is Dr. Telivala's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Telivala is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Telivala's licenses on file in 2 states: Florida and Pennsylvania.

Specialties and state licenses

  • Hematology and oncology, FloridaPrimaryLicense ME 106137 · 2010 to 2026 · taxonomy 207RH0003X
  • Internal medicine, PennsylvaniaLicense MT 183359 · 2004 to 2010 · taxonomy 207R00000X

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, immune deficiency disease and lung cancer among the conditions Dr. Telivala treats.

Hematologists and oncologists near Dr. Telivala

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Bijoy Pankaj Telivala billed Medicare for 67,690 services in 2024

CMS data shows 67,690 Medicare services from Dr. Telivala across 40 procedure codes in 2024, for 644 Medicare patients. Medicare paid $418,378 for them.

Medicare services, 202467,690
Medicare patients644
Paid by Medicare$418,378
Procedure codes40

Dr. Telivala's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 45,6922024: 49,8269%
Other services
2023: 16,2052024: 13,25318%
Tests and treatments
2023: 1,1982024: 1,1306%
Lab and pathology
2023: 1,0532024: 1,0213%
Office and hospital visits
2023: 1,0642024: 9996%
Surgery
2023: 1,0022024: 9921%
Imaging
2023: 3312024: 46942%

Where Dr. Telivala's Medicare services took place, 2024

  • In an office67,524100%
  • In a facility1660%

Dr. Telivala compared with the Florida median for hematologists and oncologists, 2024

  • Dr. Telivala
  • Florida median
Medicare services
67,690vs 69797.1 times
Medicare patients
644vs 2183.0 times
Part D claims
619vs 34182% above

Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Telivala's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Telivala

Need commercial claims for Dr. Telivala?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Telivala and other hematologists and oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Bijoy Pankaj Telivala treated 644 Medicare patients in 2024, average age 75

CMS counts 644 Medicare patients who saw Dr. Telivala in 2024. The largest group is 75 to 84, with 262 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Telivala's median patient age at 67, with 57% women.

Medicare patients, 2024644
Average age75
Average risk score2.31
Also on Medicaid7%

Dr. Telivala's Medicare patients by age, 2024

Dr. Telivala's Medicare patients by sex, 2024

  • Women33352%
  • Men31148%

Chronic conditions among Dr. Telivala's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer51%
  4. Arthritis49%
  5. Ischemic heart disease45%
  6. Chronic kidney disease41%
  7. Diabetes41%
  8. Heart failure32%

Share of Medicare patients with each condition. A patient can have several.

Dr. Telivala's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women57%
  • Men42%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Bijoy Pankaj Telivala wrote 879 Medicare Part D claims in 2024

In 2024, Dr. Telivala wrote 879 Medicare Part D claims for 141 patients. 70% of them were for generic drugs. CMS names the drug for 619 of them, across 19 drugs with 11 or more claims each, at $1,216,635 in total drug cost. In 2023, CMS named 610 claims across 22 drugs.

Part D claims, 2024879
Drugs named by CMS19
Total drug cost$1.2M
Part D patients141

Dr. Telivala's Part D claims by kind of drug, 2024

  • Generic613 claims70%
  • Brand-name266 claims30%

Dr. Telivala's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Telivala's Part D claims, 2024

  • Opioids4%37 of 879 claims
  • Antibiotics2%19 of 879 claims
  • Antipsychotics, patients 65 and over3%26 of 879 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 6102024: 6191%

Drugs named by CMS: 19 in 2024, 22 in 2023.

See all prescribing by Dr. Telivala

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Bijoy Pankaj Telivala offers telehealth to Medicare patients

Dr. Telivala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Telivala as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Telivala by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Bijoy Pankaj Telivala has 4 publications on record

Dmand AI links 4 papers to Dr. Telivala, published from 2023 to 2025. Dr. Telivala's most frequent co-authors are Avani Shah, MD, Joanne Lorraine Blum, MD and Hardik Satish Chhatrala, MD.

Papers4
Years published2023 to 2025

Dr. Telivala's papers by year, 2023 to 2025

Dr. Telivala's most frequent co-authors

Recent publications by Dr. Telivala

See all 4 publications and co-authors

See who Dr. Telivala researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Telivala works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Bijoy Pankaj Telivala has worked on 1 clinical trial

Dmand AI links Dr. Telivala to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.

Conditions in Dr. Telivala's trials

  • Breast Neoplasms
  • Breast Diseases

Investigators on the most trials with Dr. Telivala

Recent clinical trials with Dr. Telivala

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Bijoy Pankaj Telivala received $9,269 in industry payments from 2016 to 2025

CMS Open Payments shows 101 general payments to Dr. Telivala from 36 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. Pfizer Inc. paid the most, $7,730. It also lists 5 research payments totaling $5,740 from 2021 to 2023.

General payments to Dr. Telivala by program year, 2016 to 2025

General payments to Dr. Telivala by kind, 2016 to 2025

$9.3Kin total
  • Consulting fees$5,00054%
  • Speaker and faculty fees$2,54027%
  • Food and beverage$1,65018%
  • Education$781%

Companies that paid Dr. Telivala the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Telivala

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Bijoy Pankaj Telivala has 1 award and honors on record

Dmand AI lists 1 award for Dr. Telivala, most recently CMS Stage 1 EHR in 2013.

Awards and honors for Dr. Telivala

  1. 2013
    • CMS Stage 1 EHR

Source: Dmand AI Professional Profile Data

Dr. Bijoy Pankaj Telivala graduated from Lokmanya Tilak Municipal Medical College

Dr. Telivala graduated from Lokmanya Tilak Municipal Medical College in 2002.

  1. Medical schoolLokmanya Tilak Municipal Medical College
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Bijoy Pankaj Telivala accepts plans from 19 insurance carriers

Dr. Telivala is in network with 19 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.

Plan types Dr. Telivala accepts, by number of carriers

  1. PPO13
  2. HMO9
  3. Medicare9
  4. POS5
  5. EPO4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Bijoy Pankaj Telivala's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Bijoy Pankaj Telivala

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Bijoy Pankaj Telivala's NPI number?

Dr. Bijoy Pankaj Telivala's NPI number is 1790935153. It was assigned on September 23, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Bijoy Pankaj Telivala?

Dr. Bijoy Pankaj Telivala is a hematologist and oncologist in Jacksonville, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Bijoy Pankaj Telivala practice?

Dr. Telivala practices at 7015 A C Skinner Pkwy, Jacksonville, FL 32256. Dr. Telivala's primary practice is Cancer Specialists of North Florida in Jacksonville, Florida. Dmand AI also links Dr. Telivala to 2 hospitals and 1 group practice or clinic.

What is Dr. Bijoy Pankaj Telivala's office phone number?

The practice phone on file for Dr. Telivala is (904) 363-2113.

What is Dr. Bijoy Pankaj Telivala's medical license number?

Dr. Telivala holds Florida license ME 106137, one of the licenses on file in 2 states.

Which states has Dr. Bijoy Pankaj Telivala been licensed in?

Dmand AI has state licenses on file for Dr. Telivala in Florida (2010 to 2026) and Pennsylvania (2004 to 2010).

Which hospitals is Dr. Bijoy Pankaj Telivala affiliated with?

Dr. Telivala is affiliated with Baptist Medical Center Jacksonville. Dmand AI links Dr. Telivala to 2 more hospitals.

What medical group is Dr. Bijoy Pankaj Telivala part of?

Dr. Telivala is linked to Cancer Specialists of North Florida.

Does Dr. Bijoy Pankaj Telivala accept Medicare?

Yes. CMS data shows Dr. Telivala billed Medicare for 67,690 services in 2024, and Dr. Telivala accepts Medicare assignment.

Does Dr. Bijoy Pankaj Telivala offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Telivala as offering telehealth services.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Bijoy Pankaj Telivala see?

CMS counts 644 Medicare patients who saw Dr. Telivala in 2024, with an average age of 75.

Is Dr. Bijoy Pankaj Telivala board certified?

Yes. Dr. Telivala is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Bijoy Pankaj Telivala bill to Medicare?

In 2024, Dr. Telivala's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J0881) and medicare temporary code (Q9967).

Where did Dr. Bijoy Pankaj Telivala go to medical school?

Dr. Telivala graduated from Lokmanya Tilak Municipal Medical College in 2002.

What drugs does Dr. Bijoy Pankaj Telivala prescribe most?

In 2024 Medicare Part D data, Dr. Telivala's most prescribed drugs by claims were Prednisone, Eliquis and Ondansetron HCl.

Has Dr. Bijoy Pankaj Telivala received payments from drug or device companies?

CMS Open Payments shows $9,269 in general payments to Dr. Telivala from 36 companies from 2016 to 2025. The largest total came from Pfizer Inc.

How long has Dr. Bijoy Pankaj Telivala been practicing?

Dr. Telivala graduated from medical school in 2002, 24 years ago.

Does Dr. Bijoy Pankaj Telivala do research?

Dmand AI links 4 publications to Dr. Telivala, published from 2023 to 2025. Dr. Telivala has worked on 1 clinical trial.

Who does Dr. Bijoy Pankaj Telivala publish with?

Dr. Telivala's most frequent co-authors are Avani Shah, MD (2 shared papers), Joanne Lorraine Blum, MD (1 shared paper) and Hardik Satish Chhatrala, MD (1 shared paper).

What insurance does Dr. Bijoy Pankaj Telivala accept?

Dr. Telivala is in network with 19 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)